Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 31 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 9550837

    Therapeutic uses of anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  2. US 9546218

    Anti-Tie2 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  3. US 9546370

    QSOX1 as an anti-neoplastic drug target

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  4. US 9545461

    Anti-microbial peptides and methods of use thereof

    The Regents of the University of California · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  5. US 9545451

    Anti-PRLR antibodies and methods for killing PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  6. US 9540449

    Anti-PCSK9 antibodies with pH-dependent binding characteristics

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  7. US 9533039

    Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  8. US 9534033

    Targeted interferons demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  9. US 9527917

    Nucleic acid encoding anti-OX40 antibodies

    The Board of Regents of the University of Texas System · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  10. US 9527919

    High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

    The Regents of the University of California · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  11. US 9522955

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  12. US 9517243

    Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  13. US 9512125

    Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  14. US 9506926

    Molecular predictors of therapeutic response to specific anti-cancer agents

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  15. US 9499554

    Anti-influenza compositions and methods

    BioCryst Pharmaceuticals, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  16. US 9487573

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  17. US 9475875

    Anti-EGFRvIII antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  18. US 9475880

    Anti-CD134 (OX40) antibodies and uses thereof

    Biocerox Products B.V. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  19. US 9463216

    Poly-glutamic acid anti-anthrax compositions and methods for using the same

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  20. US 9458442

    Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

    HALOZYME, INC. · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  21. US 9453072

    Anti-IL-33 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  22. US 9446125

    Anti-EphA2 antibodies and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  23. US 9441050

    High-affinity monoclonal anti-prion antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  24. US 9427447

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.